Skip to main content
logo
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.010
+0.010 (0.25%)
At close: Sep 21, 2026, 4:00 PM EDT
3.970
-0.040 (-1.00%)
After-hours: Sep 21, 2026, 7:30 PM EDT

IMDX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
131215402138200
Market Cap Growth
38.57%436.55%94.02%-45.76%-80.98%24.52%
Enterprise Value
116199411414162
Last Close Price
4.007.502.382.506.4243.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
77.0153.0221.3013.7439.7491.06
PB Ratio
--6.83-3.260.810.963.07

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
67.9549.1821.649.6015.0773.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.12-0.11-0.300.110.090.09
Debt / EBITDA Ratio
0.010.010.010.00--
Net Debt / Equity Ratio
0.710.260.41-0.26-0.43-0.43
Net Debt / EBITDA Ratio
0.440.290.230.320.721.44
Net Debt / FCF Ratio
0.490.320.230.280.340.74
Asset Turnover
0.040.130.030.020.010.02
Inventory Turnover
1.904.09----
Quick Ratio
1.751.051.411.381.852.50
Current Ratio
2.001.271.621.492.112.77
Return on Equity (ROE)
---910.86%-76.26%-35.52%-88.37%
Return on Assets (ROA)
-57.82%-62.66%-26.42%-15.91%-13.88%-13.82%
Return on Capital Employed (ROCE)
-193.10%-222.90%-83.60%-32.90%-32.80%-16.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-38.38%-23.36%-151.40%-134.52%-191.48%-32.03%
FCF Yield
-24.10%-11.80%-52.92%-114.30%-131.09%-19.08%
Buyback Yield / Dilution
-52.34%-133.16%-70.84%-38.10%-24.61%-35.80%
SEC Filings: 10-K · 10-Q